Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis
Clinical trial NCT01675297 · COMPLETED
Trial details
- NCT number
- NCT01675297
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-04
- Primary completion
- 2013-12-01
- Enrollment
- 1053
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.